Items where authors include "Bowman, A."

Article

Coleman, R.E., Collinson, M., Gregory, W. et al. (20 more authors) (2018) Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04). JOURNAL OF BONE ONCOLOGY, 13. pp. 123-135. ISSN 2212-1374

Brown, J., Rathbone, E., Hinsley, S. et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. JNCI: Journal of the National Cancer Institute, 110 (8). pp. 871-879. ISSN 0027-8874

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Wardley, A.M., Hiller, L., Howard, H.C. et al. (8 more authors) (2008) tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation. British Journal of Cancer, 99 (4). pp. 597-603. ISSN 0007-0920

Monograph

Barbera, F., Barnet, O., Bassens, D. et al. (23 more authors) (2020) What comes after the pandemic? A ten-point platform for foundational renewal. Report. The Foundational Economy Collective , Manchester, UK.